Publication:
Cervical cancer screening guidelines: An updated review

dc.contributor.authorSuwicha Chittithawornen_US
dc.contributor.authorChuenkamon Charakornen_US
dc.contributor.authorChompunoot Kongsawatvorakulen_US
dc.contributor.otherRamathibodi Hospitalen_US
dc.date.accessioned2022-08-04T09:18:51Z
dc.date.available2022-08-04T09:18:51Z
dc.date.issued2021-07-01en_US
dc.description.abstractScreening is one of the strategies for cervical cancer elimination. Since the beginning of cytology to the modern era of primary HPV screening, there were various different clinical guidelines. All of the guidelines aim to detect preinvasive lesion that leads to cervical cancer; however, each guideline has dissimilar recommendation with explicable reason lying underneath. To be able to choose the suitable method of screening for individual patient would be advantage in both oncologic outcome and cost-effectiveness. This review was written to summarize the detail of changes and differences through clinician's point of view.en_US
dc.identifier.citationThai Journal of Obstetrics and Gynaecology. Vol.29, No.4 (2021), 186-190en_US
dc.identifier.issn26730871en_US
dc.identifier.issn08576084en_US
dc.identifier.other2-s2.0-85114408612en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/78050
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85114408612&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleCervical cancer screening guidelines: An updated reviewen_US
dc.typeReviewen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85114408612&origin=inwarden_US

Files

Collections